Lataa...
Immune-based therapies in acute leukemia
Treatment resistance remains a leading cause of acute leukemia -related deaths. Thus, there is an unmet need to develop novel approaches to improve outcome. New immune-based therapies with chimeric antigen receptor (CAR) T cells, bi-specific T cell engagers (BiTEs) and immune checkpoint blockers (IC...
Tallennettuna:
| Julkaisussa: | Trends Cancer |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6859901/ https://ncbi.nlm.nih.gov/pubmed/31706508 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trecan.2019.07.009 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|